Results 41 to 50 of about 152,056 (303)

A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist

open access: yesРациональная фармакотерапия в кардиологии, 2019
Modern tactics of antihypertensive therapy with fixed dose combination or with free combinations of antihypertensive drugs are reviewed in the article. The evidence that a flexible regimen of combination antihypertensive therapy is more reasonable in the
S. R. Gilyarevskiy   +4 more
doaj   +1 more source

A study on cost analysis of oral antihypertensive drugs available in India

open access: yesJournal of Applied Pharmaceutical Research, 2022
The major health care problem in developing world is shifting from communicable diseases to non-communicable disease which causes morbidities more than mortality affecting the personal efficiency.
AVANTHI E   +4 more
doaj   +1 more source

Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials. [PDF]

open access: yes, 2015
open9Atherosclerotic renal artery stenosis can cause ischaemic nephropathy and arterial hypertension. We herein review the observational and randomized clinical trials (RCTs) comparing medical and endovascular treatment for control of hypertension and ...
Caielli, P   +8 more
core   +1 more source

Antihypertensive drugs

open access: yesPharmacological Research, 2017
Successful treatment of hypertension is possible with limited side effects given the availability of multiple antihypertensive drug classes. This review describes the various pharmacological classes of antihypertensive drugs, under two major aspects: their mechanisms of action and side effects.
openaire   +2 more sources

Toxicity Profiling and In Vivo Metabolism of Danshensu-Derived Novel Antihypertensive Candidate 221s (2,9)

open access: yesToxins
Compound 221s (2,9) is a novel antihypertensive drug candidate synthesized utilizing danshensu, borneol, and proline by using the strategy of combinatorial molecular chemistry.
Yunmei Chen   +5 more
doaj   +1 more source

Effect of Hypertension on Outcomes of High-Risk Patients After BCG-Treated Bladder Cancer [PDF]

open access: yes, 2015
Immunotherapy with Bacillus Calmette Guerin (BCG) is the most efficacious treatment for high-risk bladder cancer (BC) (Ta/T1 or carcinoma in situ) to reduce the risk of recurrence.
Alberto, Bovo   +5 more
core   +1 more source

Effect of amaranth proteins on the RAS system: In vitro, in vivo and ex vivo assays [PDF]

open access: yes, 2020
The aim of this work was to analyse the hypotensive effect of amaranthprotein/peptides on spontaneously hypertensive rats (SHR). The mechanism of action of these peptides was studied in vivo and ex vivo.
Aphalo, Paula   +4 more
core   +2 more sources

Insufficient control of blood pressure and incident diabetes [PDF]

open access: yes, 2009
OBJECTIVE: Incidence of type 2 diabetes might be associated with preexisting hypertension. There is no information on whether incident diabetes is predicted by blood pressure control.
CHINALI, MARCELLO   +8 more
core   +2 more sources

Resistant and undertreated hypertension in patients with chronic kidney disease: data from the PATRIOTIC survey

open access: yesClinical and Experimental Hypertension, 2018
Background: Hypertension is prevalent in chronic kidney disease (CKD), but the control of hypertension is suboptimal. We reported the prevalence and characteristics of resistant and undertreated hypertension based on a nationwide survey aiming to improve
Ying Zheng   +8 more
doaj   +1 more source

Prescription pattern of antihypertensive drugs in Family Practice Clinics at Jordan University Hospital

open access: yesMedicine Science, 2013
The present study represents the current prescribing trend for antihypertensive drugs in family medicine clinics at Jordan University Hospital in Jordan. The study sample involved 416 male and female hypertensive Jordanian patients.
Essam Al-Drabah   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy